According to the study, called “The Influence of Female Directors on Product Recall Decisions,” highly-defective medical products and treatments are recalled 28 days faster – 35% faster – when more than one woman is on the board of directors, compared to all-male boards.
Coronavirus Treatments – If More Women Are On The Board, It’s Likely Safer, New Study Finds
